Humana (NYSE:HUM) Trading Up 0.1%

Humana Inc. (NYSE:HUM)’s stock price traded up 0.1% during mid-day trading on Monday . The company traded as high as $322.89 and last traded at $320.75. 336,794 shares were traded during trading, a decline of 83% from the average session volume of 1,972,597 shares. The stock had previously closed at $320.54.

Analyst Upgrades and Downgrades

HUM has been the topic of several research analyst reports. TD Cowen lowered their price objective on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a report on Tuesday, April 2nd. Oppenheimer reduced their price objective on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research note on Thursday, April 25th. Bank of America reaffirmed a “neutral” rating and set a $342.00 target price (down previously from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating and reduced their target price for the company from $595.00 to $360.00 in a research report on Thursday, January 25th. Finally, The Goldman Sachs Group decreased their price target on shares of Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus price target of $424.50.

Humana Stock Performance

The firm has a market capitalization of $38.47 billion, a price-to-earnings ratio of 19.88, a PEG ratio of 1.86 and a beta of 0.49. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. The firm has a 50 day moving average price of $323.55 and a 200-day moving average price of $387.14.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.12 by $1.11. Humana had a return on equity of 17.76% and a net margin of 1.82%. The business had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter last year, the business posted $9.38 EPS. The business’s quarterly revenue was up 10.7% compared to the same quarter last year. As a group, sell-side analysts expect that Humana Inc. will post 16.18 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a $0.885 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.11%. Humana’s payout ratio is 22.04%.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were bought at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the purchase, the director now directly owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.29% of the company’s stock.

Hedge Funds Weigh In On Humana

Several hedge funds have recently added to or reduced their stakes in HUM. Dorsey & Whitney Trust CO LLC grew its stake in Humana by 2.6% during the 3rd quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after buying an additional 21 shares during the last quarter. First Financial Corp IN grew its position in shares of Humana by 7.2% during the fourth quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after acquiring an additional 23 shares during the last quarter. First Trust Direct Indexing L.P. raised its position in Humana by 0.8% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock valued at $1,424,000 after purchasing an additional 24 shares during the last quarter. Nvwm LLC raised its position in Humana by 41.0% in the 3rd quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock valued at $42,000 after purchasing an additional 25 shares during the last quarter. Finally, Aurora Investment Counsel boosted its stake in Humana by 1.3% during the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock worth $1,155,000 after purchasing an additional 29 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.